Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Norihisa Ohtake, Satoko Matsunaga, Yutaro Yamaoka, Mayuko Nishi, Takeshi Morita, Ryo Saji, Mototsugu Nishii, Hirokazu Kimura, Hideki Hasegawa, Ichiro Takeuchi, Akihide Ryo
doi: https://doi.org/10.1101/2020.07.20.20158410
Kei Miyakawa
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
Sundararaj Stanleyraj Jeremiah
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
Norihisa Ohtake
2Advanced Medical Research Center, Yokohama City University, Kanagawa 236-0004, Japan
Satoko Matsunaga
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
Yutaro Yamaoka
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
3Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Kanagawa 259-1146, Japan
Mayuko Nishi
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
Takeshi Morita
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
Ryo Saji
4Department of Emergency Medicine, Yokohama City University Hospital, Kanagawa 236-0004, Japan
Mototsugu Nishii
4Department of Emergency Medicine, Yokohama City University Hospital, Kanagawa 236-0004, Japan
Hirokazu Kimura
5School of Medical Technology, Faculty of Health Sciences, Gunma Paz University, Gunma 370-0006, Japan
Hideki Hasegawa
6Influenza Research Center, National Institute of Infectious Diseases, Tokyo 208-0011, Japan
Ichiro Takeuchi
4Department of Emergency Medicine, Yokohama City University Hospital, Kanagawa 236-0004, Japan
Akihide Ryo
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
2Advanced Medical Research Center, Yokohama City University, Kanagawa 236-0004, Japan
Data Availability
All relevant data are available from the authors on request.
Posted July 22, 2020.
Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Norihisa Ohtake, Satoko Matsunaga, Yutaro Yamaoka, Mayuko Nishi, Takeshi Morita, Ryo Saji, Mototsugu Nishii, Hirokazu Kimura, Hideki Hasegawa, Ichiro Takeuchi, Akihide Ryo
medRxiv 2020.07.20.20158410; doi: https://doi.org/10.1101/2020.07.20.20158410
Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Norihisa Ohtake, Satoko Matsunaga, Yutaro Yamaoka, Mayuko Nishi, Takeshi Morita, Ryo Saji, Mototsugu Nishii, Hirokazu Kimura, Hideki Hasegawa, Ichiro Takeuchi, Akihide Ryo
medRxiv 2020.07.20.20158410; doi: https://doi.org/10.1101/2020.07.20.20158410
Subject Area
Subject Areas
- Addiction Medicine (379)
- Allergy and Immunology (694)
- Anesthesia (186)
- Cardiovascular Medicine (2806)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12492)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4360)
- Geriatric Medicine (397)
- Health Economics (710)
- Health Informatics (2805)
- Health Policy (1041)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (410)
- Medical Ethics (113)
- Nephrology (458)
- Neurology (4127)
- Nursing (219)
- Nutrition (612)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (315)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (478)
- Public and Global Health (6719)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)